Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 3Terminated 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Leukemia, Myeloid, Acute 28Myelodysplastic Syndromes 19Precursor Cell Lymphoblastic Leukemia-Lymphoma 18Leukemia, Lymphocytic, Chronic, B-Cell 13Lymphoma, Non-Hodgkin 12Lymphoma 12Recurrence 11Multiple Myeloma 11Leukemia, Myelogenous, Chronic, BCR-ABL Positive 11Leukemia 9Leukemia, Biphenotypic, Acute 8Ovarian Neoplasms 7Neoplasms 7Lymphoma, Mantle-Cell 7Myeloproliferative Disorders 6Melanoma 6Lymphoma, Large B-Cell, Diffuse 6Lymphoma, B-Cell 6Hodgkin Disease 6Hematologic Neoplasms 6Lymphoma, Follicular 5Immunoproliferative Disorders 5Immune System Diseases 5Lymphoproliferative Disorders 4Lymphoma, B-Cell, Marginal Zone 4Lymphatic Diseases 4Carcinoma, Non-Small-Cell Lung 4Sarcoma 3Mesothelioma 3Lung Neoplasms 3

Interventions

pembrolizumab 6Paclitaxel 5Carboplatin 4Bevacizumab 3oregovomab 2Nivolumab 2Hyperthermic Intraperitoneal Chemotherapy 2Cisplatin 2tislelizumab 1spartalizumab 1rucaparib 1olaparib 1niraparib 1lenvatinib 1fludarabine phosphate 1fludarabine 1denileukin diftitox 1anlotinib 1Surveys and Questionnaires 1Saline Solution 1Ramucirumab 1Platinum 1Nutrition Assessment 1Neoadjuvant Therapy 1Leucovorin 1Irinotecan 1Immunotherapy, Adoptive 1Glucose 1Gemcitabine 1Fluorouracil 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Carcinoma, Ovarian Epithelial × fludarabine × Clear all
NCT04670068 2025-12-22

Phase I Study of Autologous CAR T-Cells Targeting the B7-H3 Antigen in Recurrent Epithelial Ovarian

UNC Lineberger Comprehensive Cancer Center

Phase 1 Active not recruiting
4 enrolled 8 charts
Gynecologic

Carcinoma, Ovarian Epithelial, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡